SCHEMBL29323245

SCHEMBL29323245

COC(=O)[C@H](COC[C@H](CCCNC(=O)OC(C)(C)C)NC(=O)OCc1ccccc1)NC(=O)OCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.59
MAPT P10636 2/20 0.51
PPARA Q07869 2/20 0.49
CTSS P25774 1/20 0.49
SIRT2 Q8IXJ6 1/20 0.49
SIRT1 Q96EB6 1/20 0.49
SIRT3 Q9NTG7 1/20 0.49
KLK7 P49862 3/20 0.48
KLK5 Q9Y337 3/20 0.48
PPARG P37231 1/20 0.46
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
POLB P06746 1/20 0.45
MAPK1 P28482 1/20 0.45
FOLH1 Q04609 1/20 0.45
KYNU Q16719 1/20 0.45
ITGB3 P05106 1/20 0.45
ITGA2B P08514 1/20 0.45
CTSK P43235 2/20 0.44
CAPN1 P07384 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29323242 0.89 SYK (0.60) SYKMAPTPPARACTSSKLK7
SCHEMBL29323038 0.89 SYK (0.59) SYKMAPTPPARACTSSKLK7
SCHEMBL7424195 0.88 SYK (0.58) SYKMAPTPPARACTSSSIRT2
SCHEMBL7425992 0.88 SYK (0.58) SYKMAPTPPARACTSSSIRT2
SCHEMBL22574551 0.88 SYK (0.64) SYKMAPTPPARACTSSSIRT2
SCHEMBL22574549 0.88 SYK (0.64) SYKMAPTPPARACTSSSIRT2
SCHEMBL21900170 0.88 SIRT2 (0.60) SYKMAPTCTSSSIRT2SIRT1
SCHEMBL21900169 0.88 SIRT2 (0.60) SYKMAPTCTSSSIRT2SIRT1
SCHEMBL19295560 0.88 SIRT2 (0.60) SYKMAPTCTSSSIRT2SIRT1
SCHEMBL31072474 0.87 MAPT (0.57) SYKMAPTPPARACTSSKLK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239771-A1 BACTERIAL EFFLUX PUMP INHIBITORS TAXIS PHARMACEUTICALS, INC. 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239771-A1 BACTERIAL EFFLUX PUMP INHIBITORS ABCB11, ABCB1, SLC47A1 SYK 4472/4885MAPT 4313/4885PPARA 3159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.